A Study to Investigate How Well Ravagalimab (ABBV-323) Works and How Safe it is in Participants With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
Public ClinicalTrials.gov record NCT03695185. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Single Arm, Open-label Study to Investigate the Efficacy and Safety of Ravagalimab (ABBV-323) in Subjects With Moderate to Severe Ulcerative Colitis Who Failed Prior Therapy
Study identification
- NCT ID
- NCT03695185
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- AbbVie
- Industry
- Enrollment
- 42 participants
Conditions and interventions
Conditions
Interventions
- Ravagalimab 600 mg Drug
- Ravagalimab 300 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 25, 2019
- Primary completion
- Apr 4, 2021
- Completion
- Jan 9, 2022
- Last update posted
- Mar 14, 2023
2019 – 2022
United States locations
- U.S. sites
- 12
- U.S. states
- 7
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Banner University Medical Cent /ID# 208392 | Tucson | Arizona | 85724 | — |
| Meridian Investigator Network /ID# 204646 | Huntington Beach | California | 92648-5994 | — |
| Meridian Investigator Network /ID# 218568 | Lakewood | California | 90712 | — |
| TLC Clinical Research Inc /ID# 206626 | Los Angeles | California | 90048 | — |
| Orange County Institute of Gastroenterology and Endoscopy /ID# 207405 | Mission Viejo | California | 92691-6306 | — |
| UC Davis Medical Center /ID# 209402 | Sacramento | California | 95817 | — |
| The University of Chicago DCAM /ID# 207086 | Chicago | Illinois | 60637 | — |
| Affinity Clinical Research /ID# 206211 | Oak Brook | Illinois | 60523-1245 | — |
| Univ New Mexico /ID# 208817 | Albuquerque | New Mexico | 87131 | — |
| Penn Presbyterian Medical Center /ID# 206826 | Philadelphia | Pennsylvania | 19104-2640 | — |
| Vanderbilt University Medical Center /ID# 204670 | Nashville | Tennessee | 37232-0011 | — |
| Clinical Associates in Research Therapeutics of America, LLC /ID# 204689 | San Antonio | Texas | 78212 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03695185, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 14, 2023 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03695185 live on ClinicalTrials.gov.